Performance of C-reactive protein and procalcitonin to distinguish viral from bacterial and malarial causes of fever in Southeast Asia

BMC Infectious Diseases

Volumn 15, Issue 1, 2015, Pages

  Lubell, Yoel ^a,b   Blacksell, Stuart D ^a,b   Dunachie, Susanna ^a,b   Tanganuchitcharnchai, Ampai ^a   Althaus, Thomas ^a   Watthanaworawit, Wanitda ^a,c   Paris, Daniel H ^a,b   Mayxay, Mayfong ^b,d,e   Peto, Thomas J ^a,b   Dondorp, Arjen M ^a,b   White, Nicholas J ^a,b   Day, Nicholas P J ^a,b   Nosten, François ^a,b,c   Newton, Paul N ^b,d   Turner, Paul ^a,b,f  

^a MAHIDOL UNIVERSITY   (Thailand)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c SHOKLO MALARIA RESEARCH UNIT   (Thailand)

^d MAHOSOT HOSPITAL   (Laos)

^e UNIVERSITY OF HEALTH SCIENCES   (Laos)

^f Angkor Hospital for Children   (Cambodia)

Author keywords

Bacterial infections; C reactive protein; Fever; Malaria; Procalcitonin; Sensitivity and specificity; Sepsis; Southeast Asia

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; PROCALCITONIN; CALCA PROTEIN, HUMAN; CALCITONIN; CALCITONIN GENE RELATED PEPTIDE; PROTEIN PRECURSOR;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ARTICLE; BACTERIAL INFECTION; BACTERIUM IDENTIFICATION; BLOOD CULTURE; CAMBODIA; CHILD; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIFFERENTIAL DIAGNOSIS; FEMALE; FEVER; GEOGRAPHIC DISTRIBUTION; HOSPITAL ADMISSION; HUMAN; LAOS; MAJOR CLINICAL STUDY; MALARIA; MALE; MIXED INFECTION; MULTICENTER STUDY; NONHUMAN; PRESCHOOL CHILD; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RURAL AREA; SENSITIVITY AND SPECIFICITY; SOUTHEAST ASIA; THAILAND; VIRUS INFECTION; BACTEREMIA; BACTERIAL INFECTIONS; BLOOD; EPIDEMIOLOGY; METABOLISM; MICROBIOLOGY; PNEUMONIA; VIROLOGY; VIRUS DISEASES; YOUNG ADULT;

ADOLESCENT; ADULT; ASIA, SOUTHEASTERN; BACTEREMIA; BACTERIAL INFECTIONS; BIOMARKERS; C-REACTIVE PROTEIN; CALCITONIN; CALCITONIN GENE-RELATED PEPTIDE; CAMBODIA; CHILD; CHILD, PRESCHOOL; FEMALE; FEVER; HUMANS; LAOS; MALARIA; MALE; PNEUMONIA; PROSPECTIVE STUDIES; PROTEIN PRECURSORS; SENSITIVITY AND SPECIFICITY; THAILAND; VIRUS DISEASES; YOUNG ADULT;

EID: 84947865639     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/s12879-015-1272-6     Document Type: Article

References (43)

1. Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380(9859):2095-128.
2. Hart C, Kariuki S. Antimicrobial resistance in developing countries. BMJ. 1998;317(7159):647.
3. Okeke IN, Laxminarayan R, Bhutta ZA, Duse AG, Jenkins P, O'Brien TF, et al. Antimicrobial resistance in developing countries. Part I: recent trends and current status. Lancet Infect Dis. 2005;5(8):481-93.
4. Lubell Y, Dondorp A, Guerin PJ, Drake T, Meek S, Ashley E, et al. Artemisinin resistance--modelling the potential human and economic costs. Malar J. 2014;13:452.
5. Odaga J, Sinclair D, Lokong JA, Donegan S, Hopkins H, Garner P. Rapid diagnostic tests versus clinical diagnosis for managing people with fever in malaria endemic settings. Cochrane Database Syst Rev. 2014;4:CD008998.
6. Acestor N, Cooksey R, Newton PN, Menard D, Guerin PJ, Nakagawa J, et al. Mapping the aetiology of non-malarial febrile illness in Southeast Asia through a systematic review--terra incognita impairing treatment policies. PLoS One. 2012;7(9):e44269.
7. Chandler CI, Jones C, Boniface G, Juma K, Reyburn H, Whitty CJ. Guidelines and mindlines: why do clinical staff over-diagnose malaria in Tanzania? A qualitative study. Malar J. 2008;7(1):53.
8. Nguyen DTK, Leung KK, McIntyre L, Ghali WA, Sauve R. Does integrated management of childhood illness (IMCI) training improve the skills of health workers? A systematic review and meta-analysis. PLoS One. 2013;8(6), e66030.
9. Schuetz P, Batschwaroff M, Dusemund F, Albrich W, Burgi U, Maurer M, et al. Effectiveness of a procalcitonin algorithm to guide antibiotic therapy in respiratory tract infections outside of study conditions: a post-study survey. Eur J Clin Microbiol Infect Dis. 2010;29(3):269-77.
10. Simon L, Gauvin F, Amre DK, Saint-Louis P, Lacroix J. Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis. Clin Infect Dis. 2004;39(2):206-17.
11. Minnaard MC, van de Pol AC, Broekhuizen BD, Verheij TJ, Hopstaken RM, van Delft S, et al. Analytical performance, agreement and user-friendliness of five C-reactive protein point-of-care tests. Scand J Clin Lab Invest. 2013;73(8):627-34.
12. Oppong R, Jit M, Smith RD, Butler CC, Melbye H, Mölstad S, et al. Cost-effectiveness of point-of-care C-reactive protein testing to inform antibiotic prescribing decisions. Br J Gen Pract. 2013;63(612):e465-71.
13. Cals JW, Schot MJ, de Jong SA, Dinant GJ, Hopstaken RM. Point-of-care C-reactive protein testing and antibiotic prescribing for respiratory tract infections: a randomized controlled trial. Ann Fam Med. 2010;8(2):124-33.
14. Diez-Padrisa N, Bassat Q, Machevo S, Quinto L, Morais L, Nhampossa T, et al. Procalcitonin and C-reactive protein for invasive bacterial pneumonia diagnosis among children in Mozambique, a malaria-endemic area. PLoS One. 2010;5(10):e13226.
15. Diez-Padrisa N, Bassat Q, Morais L, O'Callaghan-Gordo C, Machevo S, Nhampossa T, et al. Procalcitonin and C-reactive protein as predictors of blood culture positivity among hospitalised children with severe pneumonia in Mozambique. Trop Med Int Health. 2012;17((9)):1100-7.
16. Page AL, de Rekeneire N, Sayadi S, Aberrane S, Janssens AC, Dehoux M, et al. Diagnostic and prognostic value of procalcitonin and C-reactive protein in malnourished children. Pediatrics. 2014;133(2):e363-370.
17. Aabenhus R, Jensen J, Jorgensen KJ, Hrobjartsson A, Bjerrum L. Biomarkers as point-of-care tests to guide prescription of antibiotics in patients with acute respiratory infections in primary care. Cochrane Database Syst Rev. 2014;11:CD010130.
18. Carrol ED, Mankhambo LA, Jeffers G, Parker D, Guiver M, Newland P, et al. The diagnostic and prognostic accuracy of five markers of serious bacterial infection in Malawian children with signs of severe infection. PLoS One. 2009;4(8):e6621.
19. Cheung YB, Zaman SM, Ruopuro ML, Enwere G, Adegbola RA, Greenwood B, et al. C-reactive protein and procalcitonin in the evaluation of the efficacy of a pneumococcal conjugate vaccine in Gambian children. Trop Med Int Health. 2008;13(5):603-11.
20. Limper M, de Kruif MD, Ajubi NE, van Zanten AP, Brandjes DP, Duits AJ, et al. Procalcitonin as a potent marker of bacterial infection in febrile Afro-Caribbean patients at the emergency department. Eur J Clin Microbiol Infect Dis. 2011;30(7):831-6.
21. Lopez AF, Cubells CL, García JG, Pou JF. Procalcitonin in pediatric emergency departments for the early diagnosis of invasive bacterial infections in febrile infants: results of a multicenter study and utility of a rapid qualitative test for this marker. Pediatr Infect Dis J. 2003;22(10):895-904.
22. Schuetz P, Christ-Crain M, Muller B. Procalcitonin and other biomarkers to improve assessment and antibiotic stewardship in infections--hope for hype? Swiss Med Wkly. 2009;139(23-24):318-26.
23. Chheng K, Carter MJ, Emary K, Chanpheaktra N, Moore CE, Stoesser N, et al. A prospective study of the causes of febrile illness requiring hospitalization in children in Cambodia. PLoS One. 2013;8(4):e60634.
24. Mayxay M, Castonguay-Vanier J, Chansamouth V, Dubot-Pérès A, Paris DH, Phetsouvanh R, et al. Causes of non-malarial fever in Laos: a prospective study. The Lancet Global Health. 2013;1(1):e46-54.
25. Dahler-Eriksen BS, Lassen JF, Petersen PH, Lund ED, Lauritzen T, Brandslund I. Evaluation of a near-patient test for C-reactive protein used in daily routine in primary healthcare by use of difference plots. Clin Chem. 1997;43(11):2064-75.
26. Aydin B, Dilli D, Zenciroglu A, Kaya O, Bilaloglu E, Okumus N, et al. Comparison of a rapid bed-side test with a central laboratory analysis for C-reactive protein in newborn infants with suspicion of sepsis. Clin Lab. 2013;59(9-10):1045-51.
27. Schuetz P, Chiappa V, Briel M, Greenwald JL. Procalcitonin algorithms for antibiotic therapy decisions: a systematic review of randomized controlled trials and recommendations for clinical algorithms. Arch Intern Med. 2011;171(15):1322-31.
28. Van den Bruel A, Thompson MJ, Haj-Hassan T, Stevens R, Moll H, Lakhanpaul M, et al. Diagnostic value of laboratory tests in identifying serious infections in febrile children: systematic review. BMJ (Clinical research ed). 2011;342:d3082.
29. Gaynes R, Levy S. Improving Outpatient Antibiotic Prescribing for Respiratory Tract Infections: Results of New Algorithms Used in European Trials. Infect Control Hosp Epidemiol. 2015;36(06):725-9.
30. Brouwer N, van Pelt J. Validation and evaluation of eight commercially available Point of Care CRP methods. Clin Chim Acta. 2015;439:195-201.
31. Phommasone K, Athaus T, Souvanthong P, Phakhounthong K, Soyvienvong L, Malapheth P et al. The Diagnostic Accuracy of Three Commercially Available C-Reactive Protein Rapid Tests in the Context of Undifferentiated Fevers in Rural Laos. BMC Infectious Diseases. Under Review.
32. Naik P, Voller A. Serum C-reactive protein levels and falciparum malaria. Trans R Soc Trop Med Hyg. 1984;78(6):812-3.
33. Kariuki SM, Gitau E, Gwer S, Karanja HK, Chengo E, Kazungu M, et al. Value of Plasmodium falciparum histidine-rich protein 2 level and malaria retinopathy in distinguishing cerebral malaria from other acute encephalopathies in Kenyan children. J Infect Dis. 2014;209(4):600-9.
34. Hendriksen IC, White LJ, Veenemans J, Mtove G, Woodrow C, Amos B, et al. Defining falciparum-malaria-attributable severe febrile illness in moderate-to-high transmission settings on the basis of plasma PfHRP2 concentration. J Infect Dis. 2013;207(2):351-61.
35. Tang H, Huang T, Jing J, Shen H, Cui W. Effect of procalcitonin-guided treatment in patients with infections: a systematic review and meta-analysis. Infection. 2009;37(6):497-507.
36. Wacker C, Prkno A, Brunkhorst FM, Schlattmann P. Procalcitonin as a diagnostic marker for sepsis: a systematic review and meta-analysis. Lancet Infect Dis. 2013;13(5):426-35.
37. Jones AE, Fiechtl JF, Brown MD, Ballew JJ, Kline JA. Procalcitonin test in the diagnosis of bacteremia: a meta-analysis. Ann Emerg Med. 2007;50(1):34-41.
38. Yo CH, Hsieh PS, Lee SH, Wu JY, Chang SS, Tasi KC, et al. Comparison of the test characteristics of procalcitonin to C-reactive protein and leukocytosis for the detection of serious bacterial infections in children presenting with fever without source: a systematic review and meta-analysis. Ann Emerg Med. 2012;60(5):591-600.
39. te Witt R, Hassing RJ, Petit PP, van Belkum A, van Genderen PJ. Procalcitonin and neopterin levels do not accurately distinguish bacterial from viral infections in ill-returned travellers with fever. Trans R Soc Trop Med Hyg. 2012;106(4):264-6.
40. Li H, Luo YF, Blackwell TS, Xie CM. Meta-analysis and systematic review of procalcitonin-guided therapy in respiratory tract infections. Antimicrob Agents Chemother. 2011;55(12):5900-6.
41. Schuetz P, Briel M, Christ-Crain M, Stolz D, Bouadma L, Wolff M, et al. Procalcitonin to Guide Initiation and Duration of Antibiotic Treatment in Acute Respiratory Infections: An Individual Patient Data Meta-Analysis. Clin Infect Dis. 2012.
42. Burkhardt O, Ewig S, Haagen U, Giersdorf S, Hartmann O, Wegscheider K, et al. Procalcitonin guidance and reduction of antibiotic use in acute respiratory tract infection. Eur Respir J. 2010;36(3):601-7.
43. van de Weg CA, Pannuti CS, de Araujo ES, van den Ham HJ, Andeweg AC, Boas LS, et al. Microbial translocation is associated with extensive immune activation in dengue virus infected patients with severe disease. PLoS Negl Trop Dis. 2013;7(5), e2236.